Jiangsu Kanion Pharmaceutical Co.,Ltd.
SHH: 600557.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Yongchun Yang
- Employees
- 5,443
- Headquarters
- Lianyungang, China
- IPO year
- 2002
- Market cap
- CN¥7.7B
- Website
- https://www.kanion.com
Loading 600557…
Loading profile data…Frequently asked questions about 600557
What does Jiangsu Kanion Pharmaceutical Co.,Ltd. (600557.SS) do?
Jiangsu Kanion Pharmaceutical Co.,Ltd. researches and develops, produces, and sells Chinese medicines. It offers medicines in the fields of gynecology, orthopedics, antiviral, cardio cerebrovascular, and other fields. The company was founded in 1975 and is based in Lianyungang, China.
Where does 600557.SS trade?
Jiangsu Kanion Pharmaceutical Co.,Ltd. (600557.SS) trades on the Shanghai Stock Exchange.
What sector is 600557.SS in?
Jiangsu Kanion Pharmaceutical Co.,Ltd. (600557.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Jiangsu Kanion Pharmaceutical Co.,Ltd.?
Yongchun Yang is the chief executive officer of Jiangsu Kanion Pharmaceutical Co.,Ltd. (600557.SS).
Where is Jiangsu Kanion Pharmaceutical Co.,Ltd. headquartered?
Jiangsu Kanion Pharmaceutical Co.,Ltd. is headquartered in China.
Does 600557.SS pay a dividend?
Yes — Jiangsu Kanion Pharmaceutical Co.,Ltd. (600557.SS) paid a trailing twelve-month dividend of CNY 0.37 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 600557.SS go public?
Jiangsu Kanion Pharmaceutical Co.,Ltd. (600557.SS) completed its initial public offering in 2002.